At Inotek, our focus is defining the future of eye care. We’re dedicated to using medical research and scientific innovation to restore and protect the vision of those suffering from diseases of the eye. With the groundbreaking discovery of trabodenoson, we’re ready to offer a pressure relieving solution for the eye with minimal side effects and no painful injections.
- Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent Read Full Press Release
- Inotek Pharmaceuticals Initiates Phase 2 Dose-ranging Trial of a Fixed-Dose Combination of Trabodenoson, a Novel Treatment for Glaucoma, and Latanoprost Read Full Press Release
- Inotek Pharmaceuticals to Present at Upcoming Investor Conferences Read Full Press Release
- Inotek Pharmaceuticals Phase 3 Development Plhan Conference Call Webcast Visit the Webcast Archive